Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Vivanza Biosciences Ltd

NSE: VIVANZA · BSE: 530057 · Pharmaceuticals & Biotechnology · 20 announcements

Share price
₹1.70
Market cap
₹6.80 Cr
Revenue (annual)
₹115.9 Cr
Net profit (annual)
₹0.39 Cr
P/E (TTM)
15.0×Sector 47.3×
Promoter holding
20.02%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

12:13 IST BSE
Annual General Meeting

Vivanza Biosciences Annual General Meeting

Vivanza Biosciences has convened its 44th AGM on September 11, 2026 via VC/OAVM. Nine agenda items cover financial statements, director appointments, and borrowing limit approvals.

11:45 IST BSE
Annual Report

Vivanza Biosciences Annual Report

Vivanza Biosciences Limited has scheduled its 44th Annual General Meeting for September 11, 2026. The company also released its full Annual Report for the financial year 2025-26.

16:06 IST BSE
Board Meeting Outcome

Vivanza Biosciences Board Meeting Outcome

Vivanza Biosciences approved its annual reports, the convening of the 44th AGM, and various procedural resolutions including borrowing limits and related party transactions for upcoming periods.

18:08 IST BSE
Board Meeting Date

Vivanza Biosciences Board Meeting Date

Vivanza Biosciences has scheduled a board meeting for August 17, 2026, to discuss the AGM, financial reports, and various corporate authorizations under the Companies Act.